|
May 3
|
Blueprint Medicines First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 2
|
Blueprint Medicines Stock Up Despite Lower-Than-Expected Q1 Earnings
|
|
May 2
|
Blueprint Medicines Corp (BPMC) Q1 2025 Earnings Call Highlights: Strong AYVAKIT Revenue Growth ...
|
|
May 2
|
Q1 2025 Blueprint Medicines Corp Earnings Call
|
|
May 1
|
Blueprint Medicines (BPMC) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 1
|
Blueprint Medicines: Q1 Earnings Snapshot
|
|
May 1
|
Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
|
|
Feb 15
|
Blueprint Medicines Full Year 2024 Earnings: EPS Beats Expectations
|
|
Feb 14
|
BPMC Q4 Earnings and Sales Miss Estimates, Shares Decline
|
|
Feb 14
|
Blueprint Medicines Corp (BPMC) Q4 2024 Earnings Call Highlights: Record Growth and Strategic ...
|
|
Feb 14
|
Q4 2024 Blueprint Medicines Corp Earnings Call
|
|
Feb 13
|
Blueprint Medicines (BPMC) Reports Q4 Loss, Misses Revenue Estimates
|
|
Feb 13
|
Blueprint Medicines: Q4 Earnings Snapshot
|
|
Feb 13
|
Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results
|
|
Feb 11
|
Earnings Preview: Axsome Therapeutics (AXSM) Q4 Earnings Expected to Decline
|
|
Jul 29
|
Earnings Preview: Tango Therapeutics, Inc. (TNGX) Q2 Earnings Expected to Decline
|
|
Jul 25
|
Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Mar 29
|
Blueprint Medicines Corporation (NASDAQ:BPMC): When Will It Breakeven?
|
|
Mar 28
|
Insiders Are Dumping These 10 Healthcare Stocks
|
|
Dec 18
|
Blueprint Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
|